Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Arthritis, Psoriatic × risankizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Psoriatic 1

Interventions

guselkumab 2 tofacitinib 1 sonelokimab 1 risankizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06641089 2026-03-11

IZAR-2

MoonLake Immunotherapeutics AG

Phase 3 Recruiting

Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡